Ganoderic Acid C1

Confirm delete?

Ganoderic Acid C1

Zoom

Cat No: 33212

Ganoderic acid C1 is a triterpenoid that has been found in G. lucidum and has diverse biological activities.{48842,58313,58311,58312} It inhibits angiotensin-converting enzyme (ACE; IC50 = 745 µM).{58313} Ganoderic acid C1 also inhibits HIV-1 protease...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Synonyms:

(7?,25R)-7-hydroxy-3,11,15,23-tetraoxo-lanost-8-en-26-oic acid

Correlated keywords:

C 1 Ganoderic acid C Ganoderma angiotensinconverting HIV1 MethA LPSinduced NF?B TNF?

Product Overview:
Ganoderic acid C1 is a triterpenoid that has been found in G. lucidum and has diverse biological activities.{48842,58313,58311,58312} It inhibits angiotensin-converting enzyme (ACE; IC50 = 745 µM).{58313} Ganoderic acid C1 also inhibits HIV-1 protease with an IC50 value of 180 µM.{48842} It reduces the proliferation of murine Lewis lung carcinoma cells but not murine Meth-A sarcoma cells (EC50s = 17 and >20 µg/ml, respectively).{58311} Ganoderic acid C1 (20 µg/ml) inhibits LPS-induced NF-κB phosphorylation and production of TNF-α in RAW 264.7 cells, as well as in peripheral blood mononuclear cells (PBMCs) isolated from patients with asthma.{58312}

Size	1 mg
Shipping	dry ice
CAS Number	95311-97-0
Molecular Formula	C₃₀H₄₂O₇
SMILES	C[C@]12C3=C(C(C[C@@]1([C@]([C@@H](CC(C[C@@H](C)C(O)=O)=O)C)([H])CC2=O)C)=O)[C@@]4([C@@](C(C)(C(CC4)=O)C)([H])C[C@@H]3O)C
Molecular Weight	514,7
Formulation	A crystalline solid
Purity	≥98%
Custom Code	2918.99
UNSPSC code	12352100

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.